Efficacy of ultraviolet Al phototherapy in recalcitrant skin diseases

Annals of Dermatology

Volumn 22, Issue 1, 2010, Pages 1-8

  Suh, Kee Suck ^a   Kang, Jin Seuk ^a   Baek, Jae Woo ^a   Kim, Tae Kwon ^a   Lee, Jin Woo ^a   Jeon, Young Seung ^a   Jang, Min Soo ^a   Kim, Sang Tae ^a  

^a Kosin University   (South Korea)

Author keywords

Recalcitrant skin disease; UVA1

Indexed keywords

EID: 77953512614     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2010.22.1.1     Document Type: Article

References (33)

1. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Crewe M, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997;186:1763-1768. (Pubitemid 27506289)
2. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997;350:12951296. (Pubitemid 28036641)
3. Grewe M, Gyufko K, Schopf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343:25-26. (Pubitemid 2008634)
4. Grabbe J, Welker P, Humke S, Grewe M, Schopf E, Henz BM, et al. High-dose ultraviolet A1 (UVA1), but not UVA/ UVB therapy, decreases IgE-binding cells in lesionai skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-422. (Pubitemid 126731702)
5. Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol 1981;77:13-19.
6. Mutzhas MF, Holzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol 1981;76:42-47. (Pubitemid 11173536)
7. Krutmann J, Czech VV, Diepgen T, Niedner R, Kapp A, Schopf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26:225-230.
8. Krutmann J, Schopf E. High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:120-122.
9. Godar DE. Preprogrammed and programmed cell death mechanisms of apoptosis: UV-induced immediate and delayed apoptosis. Photochem Photobiol 1996;63:825-830.
10. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999;112:3-12.
11. Godar DE, Lucas AD. Ultraviolet-A1 (340-400 nm)-mediated receptor and cytokine changes of transformed lymphocytes. Photodermatol Photoimmunol Photomed 2005;21:23-31.
12. Godar DE, Lucas AD. Spectral dependence of UV-induced immediate and delayed apoptosis: the role of membrane and DNA damage. Photochem Photobiol 1995;62:108-113.
13. Grewe M, Gyufko K, Krutmann J. lnterleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995;104:3-6.
14. Kowalzick L, Kleinheinz A, Weichenthal M, Neuber K, Kohler I, Grosch J, et al. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol 1995;75:43-45.
15. Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sonnichsen N, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998;38:589-593. (Pubitemid 28182930)
16. Abeck D, Schmidt T, Fesq H, Strom K, Mempel M, Brockow K, et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42:254-257. (Pubitemid 30469623)
17. Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001;45:503-507. (Pubitemid 32917242)
18. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Halfside comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000;142:39-43. (Pubitemid 30074468)
19. Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003;139:223-224. (Pubitemid 36216265)
20. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149:1095-1107. (Pubitemid 38058085)
21. Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999; 41:47-50. (Pubitemid 29336852)
22. Zane C, Leali C, Airo P, De Panfilis G, Pinton PC. "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001;44:629-633.
23. Matich AJ, Tilbury RN, Jordan TW. Characteristics of the chemiluminescence from the blood plasma of a normal human population. Photochem Photobiol 1995;62:550-556..
24. Gambichler T, Skrygan M, Tomi NS, Breuksch S, Altmeyer P, Kreuter A. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation. Br J Dermatol 2007;156:951956. (Pubitemid 46642842)
25. Cillery P, Serpier H, Polette M, Bellon G, Clavel C, Wegrowski Y, et al. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts. Eur J Cell Biol 1992;57:244-253.
26. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M. Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet 1994;343:1233. (Pubitemid 24147585)
27. Kerscher M, Meurer M, Sander C, Volkenandt M, Lehmann P, Plewig G, et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996;132:1280-1282.
28. Morison WL. Psoralen UVA therapy for linear and generalized morphea. J Am Acad Dermatol 1997;37:657-659.
29. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36:938-944. (Pubitemid 27265906)
30. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006;54:440-447. (Pubitemid 43243447)
31. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346:1166.
32. Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998;38:21-26. (Pubitemid 28100460)
33. de Rie MA, Enomoto DN, de Vries HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003;207:298-301.